News
2d
MedPage Today on MSNEnd of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts SkyrocketResearchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...
Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.
Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...
2d
News-Medical.Net on MSNResearchers identify key nerve cells behind semaglutide's appetite reductionA specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...
Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.
Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It ...
Researchers have distinguished the nerve cells in the brain that control the beneficial effects of GLP-1R agonists – such as ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Pharmaceutical Executive: What are the factors that are impacting the compounded semaglutide market? Ferrin Williams, PharmD: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results